Author:
Hassan Rasha M.,Aboutabl Mona E.,Bozzi Manuela,El-Behairy Mohammed F.,El Kerdawy Ahmed M.,Sampaolese Beatrice,Desiderio Claudia,Vincenzoni Federica,Sciandra Francesca,Ghannam Iman A.Y.
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference75 articles.
1. Early investigational drugs targeting PPAR-alpha for the treatment of metabolic disease;Liu;Expert Opin. Iinvestig. Drugs,2015
2. H. Niu, W. Wang, J. Li, Y. Lei, Y. Zhao, W. Yang, C. Zhao, B. Lin, S. Song, S. Wang, A novel structural class of coumarin-chalcone fibrates as PPARalpha/gamma agonists with potent antioxidant activities: Design, synthesis, biological evaluation and molecular docking studies, Eur. J. Med. Chem. 138 (2017) 212-220.
3. Peroxisome proliferator-activated receptors: Targets for the treatment of metabolic illnesses (Review);Moore-Carrasco;Mol. Med. Rep.,2008
4. Identification of the First PPARalpha/gamma Dual Agonist Able To Bind to Canonical and Alternative Sites of PPARgamma and To Inhibit Its Cdk5-Mediated Phosphorylation;Laghezza;J. Med. Chem.,2018
5. C. Pirat, A. Farce, N. Lebegue, N. Renault, C. Furman, R. Millet, S. Yous, S. Speca, P. Berthelot, P. Desreumaux, P. Chavatte, Targeting peroxisome proliferator-activated receptors (PPARs): development of modulators. J. Med. Chem. 55 (2012) 4027-4061.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献